Suppr超能文献

新辅助化疗后保乳手术患者的手术切缘与局部复发的关系。

Association of surgical margins with local recurrence in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy.

机构信息

Comprehensive Breast Cancer Center, Changhua Christian Hospital, 135, Nanhsiao Street, Changhua, 500209, Taiwan.

Department of Animal Science and Biotechnology, Tunghai University, Taichung, 407302, Taiwan.

出版信息

BMC Cancer. 2020 May 20;20(1):451. doi: 10.1186/s12885-020-06955-6.

Abstract

BACKGROUND

The aim of the current study was to report a single-institution experience using breast-conserving surgery after neoadjuvant chemotherapy (NACT), focusing on the association between microscopic resection margin status and locoregional recurrence (LRR).

METHODS

Our institutional prospectively maintained database was reviewed to identify patients who were treated with NACT between January 2008 and April 2018.

RESULTS

Among the main partial mastectomy specimens available for analysis (n = 161), 28 had margins < 1 mm, 21 had margin width of 1-2 mm and the remaining 112 had margins > 2 mm. LRR occurred in 16 patients (9.9%) and distant metastases were detected in 27 (16.8%) patients. There was no significant difference in the LRR between the > 2 mm margin group with a 60-month cumulative survival of 85.2% compared with 76.2% for the ≤2 mm group (P = 0.335) in the Kaplan-Meier analysis. When we stratified patients by margin widths of ≥1 mm or <  1 mm, there was no LRR-free survival benefit observed for the ≥1 mm pathologic excision margin group in the univariate analysis (hazard ratio = 0.443; 95% confidence interval = 0.142-1.383; P = 0.161) with a 60-month cumulative LRR-free survival of 84.9% compared with 69.5% for the < 1 mm margin cohort (P = 0.150).

CONCLUSIONS

In the absence of multiple scattered microscopic tumour foci, a negative margin of no ink on tumour maybe sufficient for stage I-III invasive breast cancer treated with NACT and breast-conserving surgery.

摘要

背景

本研究旨在报告单中心使用新辅助化疗(NACT)后保乳手术的经验,重点是显微镜下切缘状态与局部区域复发(LRR)之间的关系。

方法

我们回顾了机构前瞻性维护的数据库,以确定 2008 年 1 月至 2018 年 4 月期间接受 NACT 治疗的患者。

结果

在可分析的主要部分乳房切除术标本中(n=161),28 例切缘<1mm,21 例切缘宽度为 1-2mm,112 例切缘>2mm。16 例(9.9%)患者发生 LRR,27 例(16.8%)患者出现远处转移。Kaplan-Meier 分析显示,>2mm 切缘组 60 个月累积生存率为 85.2%,与≤2mm 组的 76.2%(P=0.335)无显著差异。当我们按切缘宽度≥1mm 或<1mm 分层患者时,在单因素分析中,≥1mm 病理切缘组无 LRR 无生存获益(风险比=0.443;95%置信区间=0.142-1.383;P=0.161),60 个月累积 LRR 无生存率为 84.9%,而<1mm 切缘组为 69.5%(P=0.150)。

结论

在没有多个分散的显微镜下肿瘤灶的情况下,对于接受 NACT 和保乳手术治疗的 I-III 期浸润性乳腺癌,无肿瘤墨染的阴性切缘可能是足够的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c10e/7238655/88118841c4e7/12885_2020_6955_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验